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1.1 Introduction
The immune system is a biophylactic tool that is
essential for humans living in symbiosis with
various pathogenic microorganisms. Immunology
is a science to understand and control the immune
system. The development of immunology is
expected to contribute not only to understanding
basic life science, that is, search for life
phenomena, but also to applications in the
medical area such as clarification and conquest of
infections, and immunological and allergic
diseases, etc.
At the Kyushu & Okinawa Summit held in July
2000, measures against infections became one of
the principal themes. Particularly, with regard to
HIV/AIDS, tuberculosis and malaria, the reduction
target up to 2010 was turned into a numerical
goal, and the strengthening of measures to realize
it was agreed on. The necessity of infection
control and development of vaccines, etc., is still
considerable throughout the world. In Japan, one
out of three people has some type of allergy, and
immunological intractable diseases (e.g.,
rheumatoid arthritis) attributable to the collapse
of the immune system are increasing, representing
one of the significant problems for modern
medicine. To solve these problems, it is necessary
to further promote immunological researches.
In the promotion strategy of prioritized areas
(decided by the Council for Science and
Technology Policy on September 21, 2001) based
on the Science and Technology Basic Plan 2001-
2005 (decided by Cabinet Meeting on March 30,
2001), “Clarification of the biophylactic
mechanism dealing with environmental factors
threatening Japanese people’s health, prevention
of diseases, and development of therapeutic
techniques” was selected as one of the subjects in
the field of life science, and the necessity for
promoting immunological researches was
indicated.
In this article, we will introduce the
achievements of recent immunological researches,
and, in addition, consider measures to further
promote immunological researches.
1.2 Summary of immunology
and achievements of recent
researches
1.2.1  Immune functions
The immune system is a surveillance network
distributed throughout the whole body as a self-
defense against extraneous antigens (pathogenic
microorganisms and foreign proteins, etc.), and
has the function of attacking a foreign body for
exclusion.
The cells involved in the immune response are
white blood cells in blood. Of white blood cells,
the principal cells involved in the immune
response and the mechanism of the immune
response are shown in Figure 1.
The extraneous antigens that invade into the
body are fragmented into small peptides by
antigen presenting cells such as dendritic cells,
and are presented to helper T cells by major
histocompatibility complex (MHC) molecules
expressing on the surface of dendritic cells.
Helper T cells that recognize this through T cell
receptors (TCR) control B cells that produce
antibody (immunoglobulin) specifically binding to
antigen, macrophages that phagocyte antigen and
disinfect, and cytotoxic T cells (killer T cells) that
directly kill infectious cells such as those infected
with a virus, in order to conduct the
comprehensive regulation, etc., of the immune
response. In addition, molecules called cytokines
play an important role in the functions of
differentiation, proliferation and interactions of
these immunocytes.
The immune system builds up a complicated
network system in which these cells and
molecules are highly controlled. A large number
of various immunocytes and cytokines were
identified owing to the progress of immunology
up to now, and the principal functions, etc., were
clarified.
1.2.2  Development of Immunology and
Characteristics of the Immune System
Immunology originated in researches on the
prevention of infections, and has been developed.
With the development, various characteristics of
the immune system have been revealed (Figure 2).
(1) Memory
In 1789, based on the empirical fact that if a
person’s disease can be cured once, the person
never develops the same disease again (no-twice
phenomenon: immune memory), Edward Jenner
(England) discovered that inoculation
(vaccination) of pus of bovine smallpox in
children could prevent the development of
smallpox. In the late 19th century, based on the
12
S C I E N C E  &  T E C H N O L O G Y  T R E N D S
Source: The material prepared by prof. Yousuke Takahama of the Instute for at the
Institute for Genome Research, University of Tokushima
Figure 1: Main cells in charge of immune response
Figure 2: Three characteristics of the immune system
Source: The material prepared by prof.Yousuke Takahama of
the Instute for at the Institute for Genome Research,
University of Tokushima
Table 1: Diseases decreased through by vaccination in the United States
* Estimate, # No. of deaths
Source: Authors' compilation on the basis of the Nature Reviews Immunology, 2000
Disease name
Number of patients (persons)
Decrease rate (%)
Maximum 1997
Diphtheria 206,939 4 99.99
Measles 894,134 138 99.98
Mumps 152,209 683 99.55
Pertussis 265,269 6,564 97.52
Polio 21,269 0 100.00 
Rubella 57,686 181 99.69
Congenital rubella syndrome 20,000 * 5 99.98
Tetanus 1,560 # 50 96.79
Influenza (< 5 years of age) 20,000 * 165 99.18
method of vaccination, Louis Pasteur (France)
discovered that various livestock diseases could be
prevented by using attenuated bacteria (vaccine
therapy).
After that, the understanding of the phenomenon
of immune “memory” that had been established up
to the early 20th century and the spread of
vaccines made great contributions toward saving
many people throughout the world from various
infections (Table 1).
(2) Specificity and diversity
The immune system produces antibodies
specifically responding to numerous antigens.
Since the latter half of the 1970s, genetic
engineering was introduced into immunology, and
it was proved that the mechanism to produce
diverse antibodies was attributed to gene re-
organization (a phenomenon in which
recombination of gene fragments occurs to
organize new genes). This achievement was
brought about by Dr. Susumu Tonegawa, the first
Japanese to win the Nobel Prize in Physiology and
Medicine.
For human antibodies, if the number of diverse
types is calculated from combinations of the
number of gene locus (domain V, domain D,
domain J), there are 2.6 x 106 types. Considering
the addition of N sequence and the diversity
(there are various theories of 105 to 1010) due to
very frequent variations of somatic cells, a
diversity of more than at least 1011 is likely.
The clarification of the specificity and diversity of
the immune system was a significant achievement
of immunology in the 1970s to the latter half of
the 1990s. The achievement is being utilized in
many forms including clinical examinations such
as cancer screening, detection of food poisoning
bacteria, and tests for environmental chemical
substances.
(3) Identification of self and non-self
Identification of “self” and “non-self” in the
immune system is an important characteristic of
such system. Clarification of the mechanism of
self-tolerance, which excludes “non-self” but does
not react to “self,” is one of the greatest targets of
modern immunology. When the mechanism of
self-tolerance, which normally functions within
the immune system, happens to collapse, an
autoimmune disease may develop, and, as such, if
it becomes possible to control the self-tolerance
mechanism, the problem of rejection in
transplantation and regenerative medicine may be
resolved.
T cells, which play the most important role in the
identification of “non-self,” are produced in the
thymus. Of hematopoietic stem cells produced in
bone marrow, those that enter the thymus repeat
rapid division and proliferation to produce a large
quantity of early T cells. The early T cells are
selected based on the reactivity of emerged T cell
receptors (TCR) against the major
histocompatibility complex (MHC) that is self
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Figure 3: Selection of T cells in the thymus
Source: The material prepared by prof. Yousuke Takahama of the Instute for at the
Institute for Genome Research, University of Tokushima
molecule, and only those that received a “positive
selection”mature to T cells (Figure 3).
The cells with a strong reactivity to MHC may
possibly react to “self” in the future, and are judged
as deleterious and receive a “negative selection”
resulting in death. The cells without reactivity to
MHC are judged as useless for future immune
responses, and receive a “null selection” resulting
in death. The cells with a moderate reactivity to
MHC are judged possible to work and useful in the
future, and receive a “positive selection” maturing
to T cells. At that time, if the reactivity to MHC is
too low, the cells cannot survive. Such strict
selection in the thymus excludes more than 90%
of early T cells.
If the process does not function well, it may
become a cause of autoimmune disease, etc. A
self-tolerance mechanism like this exists in
peripheral lymphatic tissues other than the
thymus, and such an abnormality in the immune
control system may become a cause of developing
autoimmune disease.
In recent years, researches on regenerative
medicine and gene therapy are being conducted
as important subjects. However, a significant
problem that remains unsolved is that the medical
techniques including embryonic stem cells (ES
cells) and vectors (e.g., virus as a vector of gene)
for gene introduction are rejected as “non-self.”
At present, the rejection is suppressed by
immunosuppressants, but there are many
problems such as side effects due to the reduction
of the patient’s entire immunity, and the necessity
for continuous treatment with the drugs. Thus, a
solution from a new approach not dependent on
immunosuppressants is being sought.
As a result, research attempting to solve the
problem by clarifying the immune control
mechanism, based on lymphocytes and the
immune control molecules, in order to control the
functions is currently one of the hottest themes.
1.2.3  One example of recent achievements in
immunology
(1) Immune control system
In recent years, the existence of T cells
specializing in immune control was revealed, and
as achievements of Japanese researchers, two
types of immune control T cells (CD25+CD4+ T
cells and NKT cells) were discovered. The
functions of immune control T cells are
maintenance of the take in organ transplantation,
inhibition of the development of cancer and
inhibition of allergy, and, further, their contribution
to the inhibition of the development of
autoimmune diseases was also revealed.
Therefore, this discovery is expected to contribute
to the resolution of immunological intractable
diseases that remain unsolved up to now.
(2) Induction of acquired immune tolerance
The induction of acquired immune tolerance
represents research to try to specifically induce
immune tolerance by introducing a “non-self”
ingredient (graft or vector) to the thymus and
attempting re-programming of “self” postnatally.
However, to realize this, the thymic functions must
be working even in adults.
In the past, thymic functions in adults had been
doubted because the establishment of “self” and
“non-self” was said to occur during childhood, and
after puberty the thymus was said to be replaced
by fat tissue. However, a recent research by Douek
(currently transferred to the National Institutes of
Health, U.S.A.), who had belonged to Texas
University South-Western Medical Center et al.,
using the TREC (a parameter to presume how
much time passed after production of a certain T
cell group in the thymus) revealed that the adult
thymus is not completely replaced by fat tissue,
and it continuously produces new T cells (Figure
4). Like this case, the basic concept of thymic
functions began to be reviewed.
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Figure 4: Age dependence of T cell productivity in the
thymus
Source: Douek, et al.: Nature (1998)
(3) Molecular mechanism related to the
thymic formation and functions
Researches to clarify the characteristics of the
thymus have rapidly progressed. For example,
some molecules such as a molecule involved in
the maintenance and regeneration of thymic
functions in the adult body, and a molecule
involved in the thymic formation were known.
However, the mechanism to form the thymus itself
was not yet known.
Then, for example, among variants of medaka
(Oryzias : ex., killifish), using a variant having no
thymic development, an attempt to clarify the
mechanism of the molecular structure that
controls the formation of the thymic organ, its
regeneration or development was started (a
collaborative research by Professor Yousuke
Takahama at the Institute for Genome Research,
University of Tokushima, and Kondo’s Induction
and Differentiation Project, Exploratory Research
for Advanced Technology (ERATO), Japan Science
and Technology Corporation).
1.2.4  Entire picture of
immunological researches
In Figure 5, the entire picture of immunological
researches is shown.
Immunology has to date clarified many basic
concepts including individual cells and molecules
involved in the immune response, and the
functions and relationship between immunity and
diseases. Based on the achievements, clinical
application of them was generally conducted
including the prevention of infections and
realization of transplantation therapy through the
development of vaccines and immuno-
suppressants, and the development of immune
therapy using the immune response.
However, there are many new problems that
remain unsolved. For example, it is still an
important problem for the future to tackle
emerging infectious diseases threatening today’s
people such as AIDS, and re-emerging infectious
diseases such as malaria and tuberculosis.
Allergic diseases and immunological intractable
diseases have a tendency of increasing, and, in the
therapies, development of a radical treatment
based on the immune system is desired instead of
the symptomatic therapy currently being
conducted. As causes of the onset of allergic
diseases, multiple factors such as stress and air
pollution are considered to be involved, and it is
necessary to clarify these in the future.
In the practical use of regenerative medicine and
gene therapy, the problem of rejection in the
immune system is an important problem to be
solved.
In the future, it is necessary to promote research
and development on the problems to meet the
clinical needs, as well as the development of base
technology such as database build up specifically
for the immune system. In addition, it is
imperative to promote translational researches
that apply the results of exploratory basic
researches to clinical studies.
In basic immunology, many areas remain to be
clarified. Following this, it is necessary to promote
individual immunological researches based on
original ideas in order to understand the entire
picture of the complicated immune system.
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Figure 5: Entire picture of immunological researches
1.3 Research promotion
system of immunology
1.3.1  Immunological researches in Japan
In our country, basic immunological researches
have been promoted mainly by the Ministry of
Education, Culture, Sports, Science and Technology
(MEXT), and measures against infections and
related clinical researches by the Ministry of
Health, Labour and Welfare (MHLW). As a budget
related to researches of immunology and allergy
for fiscal 2002, approximately 5,300 million yen
was allotted by MEXT, and approximately 1,300
million yen (Grant-in-Aid for Health Science Basic
Research) was allotted by MHLW. In this other,
1,500 million yen was appropriated to emerging
and re-emerging infectious diseases research, and
1,800 million yen was appropriated to AIDS
countermeasure research.
In Figure 6, the main achievements by the recent
Grant-in-Aid for Scientific Research and the Special
Coordination Funds for Promoting Science and
Technology (SCF) are shown. In addition, as one
of the researches of the Core Research for
Evaluational Science and Technology (CREST) of
the Japan Science and Technology Corporation,
“Advanced medical techniques for immunological
intractable diseases and infections, etc.” was
started in fiscal 2001.
In fiscal 2001, as the first public research
organization in Japan established specifically for
researches of immunology and allergy, the
Research Center for Allergy and Immunology
(RCAI) was started in the Institute of Physical and
Chemical Research (RIKEN). RCAI has a similar
form to that of American institutes, and all the staff
from the head of the Center to the technicians are
non-regular contract employees, and they are
evaluated every 5 years in terms of achievements
by an outside evaluation committee. RCAI aims to
establish base technology such as development of
DNA chips and building up of a database
specifically for immunology, and to promote
subject-setting-type of basic researches including
allergy control and control of the onset of
autoimmune diseases.
1.3.2  Immunological researches in the United
States
Immunological researches in the United States
are being conducted centering on the National
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Figure 6: Achievements by the Grant-in-Aid for Scientific Research and the Special Coordination Funds for Promoting
Science and Technology
Institute of Allergy and Infectious Diseases
(NIAID), which belongs to the National Institutes
of Health (NIH), and the Centers for Disease
Control (CDC).
The NIAID is conducting researches related to
infections such as AIDS, immunity-related diseases
such as allergy and asthma, and vaccine
development, together with other supporting
researches.
In the President’s budget plan for fiscal 2003, due
to the situation that 2003 is the final year of the 5-
year double budget campaign of NIH started in
1999, the budget of NIH for research and
development was substantially increased by 17.5%
compared to the previous year. In particular,
NIAID is an organization at NIH that takes the
initiative in measures against biological terrorism
and AIDS research, and, among the institutes of
NIH, the budget of NIAID was substantially
increased* by approximately 4 billion dollars
(approx. 480 billion yen), which corresponds to
approximately a 57% increase compared to the
previous year (Figure 7).
Details of the NIAID’s budget for fiscal 2001 are
shown in Figure 8. Research grants, such as
research project grants, are usually for basic
researches, and are grants for researches based on
ideas of researchers at universities or research
institutes. Not only the NIAID but also other
institutes of NIH allot approximately 70% of their
total budget to research grants.
* Tomoe Kiyosada, The Trend of the R&D
Policy in the US - Transition of priority areas
in the R&D budget allocation of the federal
government —; Science & Technology
Trends — Quarterly Review, No.4
(December 2002).
1.4 Conclusion
1.4.1  Directivity of the development of
immunology
Today, in the field of immunology, there are many
problems that remain unsolved including control
of refractory infections such as AIDS, development
of vaccines, clarification of the onset of allergic
diseases and immunological intractable diseases,
and development of preventive methods and
therapies. High expectations are placed on
regenerative medicine and gene therapy as state-
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Figure 7: Fluctuation of the budget of NIAID
Source: Authors' compilation on the basis of the home page of
NIAID
Figure 8: The Details of the budget for 2001 in NIAID
Source: NIAID Profile: Fiscal Year 2001
of-the-art therapies, but in order to put them to
practical use it is necessary to develop a technique
to control the self-tolerance mechanism.
Following this, it is necessary to solve problems
and develop base techniques to satisfy the clinical
needs.
Immunology has clarified many basic concepts
up to now including individual cells and
molecules involved in the immune response, and
the functions and relationship between immunity
and diseases. However, many phenomena remain
to be solved, and it is necessary to build up basic
knowledge and findings further. In addition, it is
necessary to comprehensively understand the
entire picture of the immune system formed by
the individual cells and molecules through their
complicated mutual relationship.
1.4.2  Measures for promotion of immunology
In order to solve problems that would satisfy
clinical needs, i.e. research and development
related to immunological and allergic diseases and
infections, as well as those that are politically
emphasized, it is necessary to promote the
following organized research and development.
• Depending on the problem (e.g., clarification
of environmental factors in the onset of
allergy), attempt to seek efficiency by means of
project-type researches such as genome
researches.
• Promote human resource exchange and
research exchange by attempting to establish
cooperation between main institutes such as
RIKEN Research Center for Allergy and
Immunology, and universities.
• In order to understand the entire picture of
the immune system including genome
information, extend efforts to promote the
development of basic technology such as
database build up specifically for the immune
system.
• Promote measures for translational researches
that apply the results obtained from basic
researches to clinical practice, for example, by
promoting cooperation between research
organizations and the hospitals belonging to
them, etc.
In order to develop basic immunology that can
clarify unsolved phenomena of the immune
system, it is necessary to promote personal-idea-
type researches based on personal intellectual
curiosity or original ideas. To realize this, it is
necessary to enrich research aid such as the Grant-
in-Aid for Scientific Research, which gives a large
degree of freedom to individual researchers.
Immunology in Japan has to date shown
achievements focusing on cytokine researches,
which are highly appreciated throughout the
world. It is necessary to improve the evaluation
system in order to aim at promoting researches
having international competitiveness and to
develop a new area in immunology. For example,
it would be necessary to make public the review
sheet for evaluations in an attempt to open up
such evaluations, and to seek greater
internationalization by adding foreign researchers
to the judges of evaluations.
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